Type IA Topoisomerases as Targets for Infectious Disease Treatments
Infectious diseases are one of the main causes of death all over the world, with antimicrobial resistance presenting a great challenge. New antibiotics need to be developed to provide therapeutic treatment options, requiring novel drug targets to be identified and pursued. DNA topoisomerases control...
Main Authors: | Ahmed Seddek, Thirunavukkarasu Annamalai, Yuk-Ching Tse-Dinh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/1/86 |
Similar Items
-
Mechanism of Type IA Topoisomerases
by: Tumpa Dasgupta, et al.
Published: (2020-10-01) -
Variation of Structure and Cellular Functions of Type IA Topoisomerases across the Tree of Life
by: Kemin Tan, et al.
Published: (2024-03-01) -
Microbial Type IA Topoisomerase C-Terminal Domain Sequence Motifs, Distribution and Combination
by: Brenda Diaz, et al.
Published: (2022-08-01) -
Localization of Mycobacterium tuberculosis topoisomerase I C-terminal sequence motif required for inhibition by endogenous toxin MazF4
by: Pamela K. Garcia, et al.
Published: (2022-12-01) -
The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
by: Seungmin Han, et al.
Published: (2022-08-01)